NewAmsterdam Pharma Chief Accounting Officer Louise Kooij disposes of ordinary shares worth $3.08 million
NAMS•Insider share transactions reported
- NewAmsterdam Pharma Chief Accounting Officer Louise Frederika Kooij reported option exercises, acquiring 105,000 ordinary shares on July 20, 2026.
- She sold 104,000 ordinary shares the same day at weighted average prices of USD 29.96, USD 31.05, USD 31.71.
- Her ordinary share holdings fell to 24,353 shares following the transactions.
Related News
Origin Bancorp Q2 net interest income rises on higher loan balances and yields
OBK•
Colony Bankcorp Q2 FY26 net income rises 32.34% to $10.9 million; net interest margin widens 0.04 percentage point to 3.52%
CBAN•
